---
title: "Sharon Bio-Medicine Ltd (SHARONBIO) — Share Price, Financials & Analysis"
symbol: "SHARONBIO"
company: "Sharon Bio-Medicine Ltd"
canonical: "https://tapetide.com/stocks/SHARONBIO"
sector: "Healthcare"
industry: "Pharmaceuticals & Biotechnology"
generated_at: "2026-09-13T19:07:58.434Z"
---

# Sharon Bio-Medicine Ltd (SHARONBIO)

Canonical page: https://tapetide.com/stocks/SHARONBIO

## Company

- **Sector:** Healthcare
- **Industry:** Pharmaceuticals & Biotechnology
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Face Value:** ₹2
- **F&O Eligible:** No
- **Website:** sharonbio.com

## About

Sharon Bio-Medicine Limited is a specialty pharmaceutical company. The Company is engaged in the development, manufacture and commercialization of pharmaceutical products. The Company operates in three segments, which include Active Pharma Ingredients (API's), Formulations and Toxicology.

## Latest Price

## Growth Rates

| Metric | 1Y | 3Y |
| --- | --- | --- |
| net income growth | 8% | 4% |
| revenue growth | 4% | 4% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 35.8 | 43.25 | 45.24 | 48.57 | 48.89 | 45.37 | 44.36 | 49.77 | 37.84 | 55.16 | 57.75 | 44.23 |
| Expenses | 31.81 | 38.6 | 38.72 | 42.11 | 42.27 | 38.52 | 38.01 | 43.4 | 36.99 | 44.46 | 47.46 | 40.72 |
| Operating Profit | 3.99 | 4.65 | 6.52 | 6.46 | 6.62 | 6.85 | 6.35 | 6.37 | 0.85 | 10.7 | 10.29 | 3.51 |
| OPM % | 11.15 | 10.75 | 14.41 | 13.3 | 13.54 | 15.1 | 14.31 | 12.8 | 2.25 | 19.4 | 17.82 | 7.94 |
| Other Income | 0.38 | 0.64 | 1.01 | 2.08 | 0.66 | 0.47 | 0.56 | 1.13 | 0.72 | 0.85 | 2.09 | 0.79 |
| Interest | 0.04 | 0.04 | 0.05 | 0.04 | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 |
| Depreciation | 2.83 | 2.88 | 2.91 | 2.89 | 2.76 | 2.82 | 2.85 | 2.8 | 2.66 | 2.69 | 2.91 | 2.49 |
| Profit before tax | 1.5 | 2.37 | 4.57 | 5.61 | 4.49 | 4.47 | 4.03 | 4.68 | -1.11 | 8.84 | 9.46 | 1.8 |
| Tax % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 1.5 | 2.37 | 4.56 | 5.61 | 4.49 | 4.48 | 4.02 | 4.68 | -1.11 | 8.85 | 9.47 | 1.81 |
| EPS in Rs | 0.13 | 0.2 | 0.38 | 0.47 | 0.38 | 0.38 | 0.34 | 0.39 | -0.09 | 0.74 | 0.8 | 0.15 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Jun 2011 | Jun 2012 | Jun 2013 | Jun 2014 | Jun 2015 | Mar 2016 9m | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 606 | 785 | 1060 | 1314 | 834 | 253 | 171 | 173 | 188 | 195 |
| Expenses | 535 | 690 | 939 | 1157 | 868 | 387 | 145 | 151 | 162 | 170 |
| Operating Profit | 71 | 95 | 120 | 157 | -34 | -134 | 26 | 22 | 26 | 25 |
| OPM % | 12 | 12 | 11 | 12 | -4.1 | -53 | 15 | 13 | 14 | 13 |
| Other Income | 1 | 1 | 1 | 2 | -74 | -69 | -72 | 4 | 3 | 4 |
| Interest | 27 | 34 | 43 | 59 | 94 | 71 | 0 | 0 | 0 | 0 |
| Depreciation | 8 | 9 | 12 | 15 | 19 | 15 | 11 | 12 | 11 | 11 |
| Profit before tax | 36 | 53 | 66 | 85 | -221 | -289 | -56 | 14 | 18 | 19 |
| Tax % | 15 | 22 | 20 | 18 | 2 | 3 | 0 | 0 | 0 | 0 |
| Net Profit | 31 | 42 | 53 | 70 | -226 | -299 | -56 | 14 | 18 | 19 |
| EPS in Rs | 2.95 | 3.94 | 5.01 | 6.59 | -18.99 | -25.16 | -4.75 | 1.18 | 1.49 | 1.6 |
| Dividend Payout % | 6 | 5 | 3 | 5 | 0 | 0 | 0 | 0 | 0 | 0 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Jun 2011 | Jun 2012 | Jun 2013 | Jun 2014 | Jun 2015 | Mar 2016 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 11 | 11 | 11 | 21 | 24 | 24 | 24 | 1 | 1 | 1 |
| Reserves | 188 | 182 | 233 | 323 | 94 | -205 | -664 | -627 | -610 | -592 |
| Borrowings | 344 | 508 | 644 | 725 | 824 | 836 | 828 | 828 | 828 | 828 |
| Other Liabilities | 44 | 74 | 84 | 92 | 69 | 68 | 88 | 88 | 80 | 76 |
| Total Liabilities | 586 | 774 | 972 | 1162 | 1012 | 723 | 276 | 290 | 299 | 313 |
| Fixed Assets | 181 | 201 | 272 | 325 | 332 | 319 | 149 | 141 | 135 | 128 |
| CWIP | 27 | 60 | 43 | 15 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 4 | 4 | 4 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 374 | 509 | 654 | 820 | 678 | 404 | 128 | 149 | 164 | 185 |
| Total Assets | 586 | 774 | 972 | 1162 | 1012 | 723 | 276 | 290 | 299 | 313 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Jun 2011 | Jun 2012 | Jun 2013 | Jun 2014 | Jun 2015 | Mar 2016 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | -36 | -53 | -70 | -69 | -82 | -28 | 35 | 4 | 23 | 41 |
| Cash from Investing Activity | -8 | -61 | -64 | -27 | -10 | 0 | -7 | -4 | -3 | -3 |
| Cash from Financing Activity | 46 | 117 | 134 | 103 | 96 | 22 | 0 | 0 | 0 | 0 |
| Net Cash Flow | 1 | 2 | 0 | 6 | 4 | -6 | 28 | 0 | 20 | 38 |
| Free Cash Flow | -46 | -115 | -135 | -101 | -93 | -30 | 27 | 0 | 18 | 36 |
| CFO/OP | -51 | -56 | -58 | -44 | 238 | 21 | 133 | 19 | 86 | 160 |

### Ratios

| Item | Jun 2011 | Jun 2012 | Jun 2013 | Jun 2014 | Jun 2015 | Mar 2016 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 116 | 121 | 122 | 115 | 138 | 264 | 47 | 62 | 52 | 49 |
| Inventory Days | 112 | 109 | 105 | 106 | 136 | 198 | 173 | 209 | 162 | 149 |
| Days Payable | 23 | 28 | 24 | 20 | 23 | 44 | 214 | 183 | 167 | 155 |
| Cash Conversion Cycle | 205 | 202 | 203 | 201 | 251 | 418 | 7 | 88 | 48 | 43 |
| Working Capital Days | 72 | 78 | 72 | 79 | 129 | 68 | -566 | -514 | -464 | -474 |
| ROCE % | 13 | 14 | 14 | 15 | -5 | -17 | — | 7 | 8 | 8 |

## Shareholding Pattern

### annual

| Category | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 32.53% | 32.53% | 32.53% | 32.53% | 0% | 0% | 0% |
| DIIs | 0.12% | 0% | 0.01% | 0.01% | 0.02% | 0.02% | 0.02% |
| Public | 67.35% | 67.47% | 67.47% | 67.46% | 99.97% | 99.97% | 99.98% |
| No. of Shareholders | 29775 | 25887 | 24825 | 24836 | 24854 | 24854 | 24837 |

### Quarterly

| Category | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 32.53% | 32.53% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0.01% | 0.01% | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% |
| Public | 67.46% | 67.46% | 99.97% | 99.97% | 99.98% | 99.97% | 99.97% | 99.97% | 99.97% | 99.99% | 99.99% | 99.98% |
| No. of Shareholders | 24836 | 24830 | 24854 | 24854 | 24854 | 24854 | 24854 | 24854 | 24853 | 24837 | 24837 | 24837 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 2 / 5 / 12

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 17.19 | Sell |
| EMA (10) | 17.26 | Sell |
| SMA (20) | 18.53 | Sell |
| EMA (20) | 18.2 | Sell |
| SMA (50) | 20.72 | Sell |
| EMA (50) | 20.58 | Sell |
| SMA (100) | 24.38 | Sell |
| EMA (100) | 23.92 | Sell |
| SMA (200) | 29.85 | Sell |
| EMA (200) | 30.35 | Sell |

### Oscillators — summary: **Neutral**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 34.79 | Neutral |
| MACD (12,26,9) | -1.26 | Sell |
| Stochastic (14,3,3) | 11.99 | Buy |
| ADX (14) | 24.89 | Neutral |
| Williams %R (14) | -88.1 | Buy |
| ATR (14) | 1.08 | High Volatility |
| ROC (12) | -8.33 | Sell |
| Stoch RSI (14) | 51.58 | Neutral |
| UO (7,14,28) | 31.89 | Neutral |

## Filings & Documents

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Annual Report 2012 from nse](https://archives.nseindia.com/annual_reports/AR_2561_SHARONBIO_2011_2012_21102013140012.zip) |
| from bse | [Annual Report 2016 from bse](https://www.bseindia.com/bseplus/AnnualReport//5329080316.pdf) |
| from bse | [Annual Report 2015 from bse](https://www.bseindia.com/bseplus/AnnualReport//5329080615.pdf) |
| from bse | [Annual Report 2014 from bse](https://www.bseindia.com/bseplus/AnnualReport//5329080614.pdf) |
| from bse | [Annual Report 2013 from bse](https://www.bseindia.com/bseplus/AnnualReport//5329080613.pdf) |
| from bse | [Annual Report 2012 from bse](https://www.bseindia.com/bseplus/AnnualReport//5329080612.pdf) |
| from bse | [Annual Report 2010 from bse](https://www.bseindia.com/bseplus/AnnualReport//5329080610.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:07:58.434Z.